Celesio AG buy matumba
Summary
This prediction ended on 01.08.12 with a price of €14.71. During the runtime of the prediction for Celesio AG the price only changed by -0.02%. matumba has 50% into this predictionCelesio is a listed healthcare company that provides wholesale, delivery, and retail distribution services for pharmaceutical and healthcare products in Europe. The company operates through its three segments: Prescription Retail, Pharmacy Wholesale, and Consumer Solutions, and its services cater to individual customers, hospitals, and healthcare professionals. Celesio also offers digital healthcare solutions and operates pharmacies across Europe. As of July 2021, Celesio's stock is trading at approximately €25 per share on the Frankfurt Stock Exchange.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Celesio AG | - | - | - | - |
iShares Core DAX® | 2.275% | 4.627% | 18.839% | 16.367% |
iShares Nasdaq 100 | 6.015% | 2.007% | 23.636% | 35.232% |
iShares Nikkei 225® | 4.456% | 3.598% | 12.437% | -0.660% |
iShares S&P 500 | 4.061% | 2.876% | 23.447% | 38.511% |
Comments by matumba for this prediction
In the thread Celesio AG diskutieren
starker auftrieb
die zugekaufte tochterfrima PANPHARMA entwickelt sich als goldgrube, der widerstadt scheint gebrochen und nun zurück zu alten werten.
mutige hatte bei unter 10,00 euro schon zugeschlagen nun sind wir dran